SCHLUMBERGER LTD (SLB)       49.1  +0.36 (+0.74%)

49.1  +0.36 (+0.74%)

AN8068571086 - Common Stock - After market: 49.1 0 (0%)


Fundamental Rating

6

Overall SLB gets a fundamental rating of 6 out of 10. We evaluated SLB against 92 industry peers in the Energy Equipment & Services industry. SLB has a great profitability rating, but there are some minor concerns on its financial health. SLB is valued quite expensive, but it does show an excellent growth.




Profitability

Profitability Rating

9

SLB's Return On Assets of 7.97% is amongst the best of the industry. SLB does better than the industry average Return On Assets of 6.20%.
SLB's Return On Equity of 19.45% is amongst the best of the industry. SLB does better than the industry average Return On Equity of 10.86%.

SLB's Profit Margin of 12.25% is amongst the best returns of the industry. SLB outperforms 81% of its industry peers. The industry average Profit Margin is 5.84%.
The Piotroski-F score of SLB is 8.00. This is a very strong score and indicates great health and profitability for SLB.
VS Industry

ROA (7.97%) VS Industry: 72% outperformed.

0.05
110,790.00

ROE (19.45%) VS Industry: 74% outperformed.

0.05
39.87

Profit Margin (12.25%) VS Industry: 81% outperformed.

0.12
114.10

Valuation

Valuation Rating

3

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Price/Earnings Ratio is 22.52, which indicates a rather expensive current valuation of SLB.
The Forward Price/Earnings Ratio of 16.12 indicates a correct valuation of SLB.
With a price book ratio of 3.94, SLB is valued correctly.

SLB's Price/Earning Ratio is slightly more expensive than the industry average, which is at 14.20.
Compared to an average industry price book ratio of 1.24, SLB is valued more expensive than its industry peers. 88% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of SLB to the average industry ratio of 7.02, SLB is valued more expensive than its industry peers.
VS Industry

Price/Earnings (22.52) VS Industry: 30% outperformed.

98.92
0.07

Price/Book (3.94) VS Industry: 12% outperformed.

94.34
0.21

Enterprise Value/ EBITDA (11.82) VS Industry: 22% outperformed.

868.22
2.22

Growth

Growth Rating

7

The Earnings Per Share has grown by an impressive 70.31% over the past year.
Based on estimates for the next 5 years, SLB will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.77% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue has grown by 22.51% in the past year. This is a very strong growth!

SLB is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 11.01% yearly.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
SLB shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 7.76% yearly.
Measured over the past 5 years, SLB shows a decrease in Revenue. The Revenue has been decreasing by -1.59% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS7.76% 14.04% 70.31% 39.76% 31.38% 26.96% 19.77%
Revenue-1.59% -5.15% 22.51% 16.32% 13.97% 12.62% 11.01%

Health

Health Rating

5

An Altman-Z score of 3.03 indicates that SLB is not in any danger for bankruptcy at the moment.
The Altman-Z score of SLB is much better than the industry average of 1.72.
The Piotroski-F score of SLB is 8.00. This is a very strong score and indicates great health and profitability for SLB.
SLB has a Current Ratio of 1.25. This is a normal value and indicates that SLB is financially healthy and should not expect problems in meeting its short term obligations.

When comparing the Current Ratio of SLB to the average industry Current Ratio of 1.81, SLB is less able to pay its short term obligations than its industry peers.
SLB has a Quick Ratio of 1.25. This is a bad value and indicates that SLB is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 1.45, SLB is worse placed to pay its short term obligations than its industry peers. 87% of its industry peers have a better Quick Ratio.
Compared to an average industry Debt to Equity Ratio of 0.38, SLB is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.6) VS Industry: 39% outperformed.

40.17
0.00

Quick Ratio (0.92) VS Industry: 13% outperformed.

0.22
8.35

Current Ratio (1.25) VS Industry: 21% outperformed.

0.22
8.60

Altman-Z (3.03) VS Industry: 75% outperformed.

-12,861.52
9.68

Dividend

Dividend Rating

5

SLB pays out 24.65% of its income as dividend. This is a sustainable payout ratio.
SLB has been paying a dividend for at least 10 years, so it has a reliable track record.
SLB has a Yearly Dividend Yield of 2.24%.

SLB's Dividend Yield is comparable with the industry average which is at 2.32.
Compared to an average S&P500 Dividend Yield of 2.60, SLB has a dividend comparable with the average S&P500 company.
The dividend of SLB decreases each year by -31.25%.
VS Industry

Dividend Yield (2.24%) VS Industry: 46% outperformed.

0.17
11.44

SCHLUMBERGER LTD49.1

NYSE:SLB (3/31/2023, 5:00:01 PM)+0.36 (+0.74%)

After market: 49.1 0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)01-20 2023-01-20/bmo
Earnings (Next)04-20 2023-04-20/bmo
Inst Owners81.79%
Inst Owner Change-0.66%
Ins Owners0.22%
Ins Owner Change15.89%
Market Cap69.73B
Analysts82.86
Price Target65.4 (33.2%)
Dividend
Industry RankSector Rank
Dividend Yield 2.24%
Dividend Growth(5Y)-31.25%
DP24.65%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-07 2023-02-07 (0.25)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.11%
Min EPS beat(2)3.1%
Max EPS beat(2)13.13%
EPS beat(4)4
Avg EPS beat(4)10.9%
Min EPS beat(4)3.1%
Max EPS beat(4)23.86%
Revenue beat(2)1
Avg Revenue beat(2)2.18%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)4.43%
Revenue beat(4)3
Avg Revenue beat(4)2.8%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)6.81%
PT rev (1m)0.23%
PT rev (3m)8.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.67%
EPS NY rev (1m)0.9%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.92%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 22.52
Fwd PE 16.12
P/S 2.48
P/FCF 33.17
P/OCF 18.74
P/B 3.94
P/tB 40.75
EV/EBITDA 11.82
EPS(TTM)2.18
EY4.44%
EPS(NY)3.05
Fwd EY6.21%
FCF(TTM)1.48
FCFY3.01%
OCF(TTM)2.62
OCFY5.33%
SpS19.78
BVpS12.45
TBVpS1.2
PEG (NY)0.57
PEG (5Y)2.9
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 19.45%
ROIC 10.87%
ROICexc 13.35%
ROICexgc 36.16%
OM 14.78%
PM 12.25%
GM 18.37%
ROICexgc(3y)22.01%
ROICexcg growth 3Y38.21%
ROICexcg growth 5Y22.91%
ROICexc(3y)8.69%
ROICexc growth 3Y30.73%
ROICexc growth 5Y25.55%
OM growth 3Y17.34%
OM growth 5Y10.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.9%
GM growth 5Y7.31%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.82
Debt/EBITDA 1.94
Cap/Depr 75.36%
Profit Quality 61.1%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 3.03
F-Score8
WACC11.52%
ROIC/WACC3.14
Cap/Depr(3y)57.56%
Cap/Depr(5y)56.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y70.31%
EPS 3Y14.04%
EPS 5Y7.76%
EPS growth Q2Q73.17%
EPS Next Y39.76%
EPS Next 2Y31.38%
EPS Next 3Y26.96%
EPS Next 5Y19.77%
Revenue growth 1Y22.51%
Revenue growth 3Y-5.15%
Revenue growth 5Y-1.59%
Revenue growth Q2Q26.55%
Revenue Next Year16.32%
Revenue Next 2Y13.97%
Revenue Next 3Y12.62%
Revenue Next 5Y11.01%
EBIT growth 1Y50.07%
EBIT growth 3Y11.3%
EBIT growth 5Y8.89%
EBIT Next Year86.13%
EBIT Next 3Y34.42%
EBIT Next 5Y23.81%
FCF growth 1Y-40.11%
FCF growth 3Y-17.23%
FCF growth 5Y-9.98%
OCF growth 1Y-20.02%
OCF growth 3Y-11.85%
OCF growth 5Y-8.06%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA